Sandoz (India) Ltd.

Alembic Pharmaceuticals receives USFDA approval for generic Difluprednate ophthalmic emulsion to treat eye inflammation and pain after surgery.

Lupin collaborates with Sandoz to commercialize biosimilar ranibizumab in multiple regions. Sandoz to handle commercialization, Lupin to manufacture.

An Australian delegation of wool farmers and entrepreneurs visited the Wool Research Centre in Thane, India, to explore research developments and assess opportunities in the wool production sector.

Caplin Point Labs receives USFDA approval for its generic version of Difluprednate eye drop, indicated for inflammation and pain after ocular surgery. The approval marks a significant milestone...

Glenmark Pharmaceuticals launches a generic glaucoma treatment, Travoprost ophthalmic solution, bioequivalent to Travatan Z. The launch expands Glenmark's ophthalmic product portfolio.

Tesla India launches EMI schemes & exchange incentives (Rs 3 lakh) to boost Model Y sales. Low down payment & monthly installments available.

US tariff cut to 18% on Indian goods boosts Bengal exports, especially in leather, footwear, and jute sectors. Employment gains expected.

Century Plyboards plans aggressive US export expansion due to favorable tariffs. Focus on laminates, cubicles, and exterior laminates.

Natco Pharma receives USFDA approval for generic Erdafitinib, a cancer drug. Expected US sales of Balversa generic are around USD 60 million.

Moody's says US tariff reduction on Indian goods is credit positive for labor-intensive sectors. Trade deal details inside.

Mayawati says it's premature to assess the US tariff cut on Indian goods. She awaits complete details and implementation to understand the impact.

Tesla India launches EMI schemes & exchange incentives (Rs 3 lakh) to boost Model Y sales. Low down payment & monthly installments available.

US tariff cut to 18% on Indian goods boosts Bengal exports, especially in leather, footwear, and jute sectors. Employment gains expected.

Adani Ports reports 21% jump in Q3 profit to Rs 3,000 cr, driven by higher cargo revenues. FY26 revenue guidance revised to Rs 38,000 crore.

Century Plyboards plans aggressive US export expansion due to favorable tariffs. Focus on laminates, cubicles, and exterior laminates.